Senzime Ab Stock Cash And Equivalents
| SEZI Stock | SEK 5.80 0.13 2.29% |
Senzime AB fundamentals help investors to digest information that contributes to Senzime AB's financial success or failures. It also enables traders to predict the movement of Senzime Stock. The fundamental analysis module provides a way to measure Senzime AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Senzime AB stock.
Senzime |
Senzime AB Company Cash And Equivalents Analysis
Senzime AB's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Senzime AB Cash And Equivalents | 74.87 M |
Most of Senzime AB's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Senzime AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Senzime AB has 74.87 M in Cash And Equivalents. This is 90.88% lower than that of the Health Care Equipment & Supplies sector and 86.58% lower than that of the Health Care industry. The cash and equivalents for all Sweden stocks is 97.23% higher than that of the company.
Senzime Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Senzime AB's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Senzime AB could also be used in its relative valuation, which is a method of valuing Senzime AB by comparing valuation metrics of similar companies.Senzime AB is currently under evaluation in cash and equivalents category among its peers.
Senzime Fundamentals
| Return On Equity | -0.64 | |||
| Return On Asset | -0.29 | |||
| Operating Margin | (8.35) % | |||
| Current Valuation | 771.13 M | |||
| Shares Outstanding | 69.88 M | |||
| Shares Owned By Insiders | 43.52 % | |||
| Shares Owned By Institutions | 17.18 % | |||
| Price To Earning | (25.28) X | |||
| Price To Book | 2.70 X | |||
| Price To Sales | 60.95 X | |||
| Revenue | 10.98 M | |||
| Gross Profit | (4.39 M) | |||
| EBITDA | (73.22 M) | |||
| Net Income | (82.14 M) | |||
| Cash And Equivalents | 74.87 M | |||
| Cash Per Share | 0.42 X | |||
| Total Debt | 617 K | |||
| Current Ratio | 3.78 X | |||
| Book Value Per Share | 3.75 X | |||
| Cash Flow From Operations | (81.33 M) | |||
| Earnings Per Share | (1.37) X | |||
| Target Price | 11.0 | |||
| Number Of Employees | 18 | |||
| Beta | 0.61 | |||
| Market Capitalization | 531.12 M | |||
| Total Asset | 174.62 M | |||
| Working Capital | 16 M | |||
| Current Asset | 18 M | |||
| Current Liabilities | 2 M | |||
| Net Asset | 174.62 M |
About Senzime AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Senzime AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Senzime AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Senzime AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Senzime Stock Analysis
When running Senzime AB's price analysis, check to measure Senzime AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senzime AB is operating at the current time. Most of Senzime AB's value examination focuses on studying past and present price action to predict the probability of Senzime AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senzime AB's price. Additionally, you may evaluate how the addition of Senzime AB to your portfolios can decrease your overall portfolio volatility.